Key facts
- Predictheon’s last known valuation is $1.3M (May 2021).
- It has raised $1.1M; the latest was Later Stage VC in Mar 2026.
- Notable investors include Clave (Pamplona), ACCIÓ, EIT Health, Grow Ventures Partners, Headstart Investor Circle — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Predictheon
- ·The full record, as it builds
Funding rounds
No funding rounds for Predictheon are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Predictheon
Developer of an artificial intelligence-based software designed to provide patient health data analysis. The company's software offers real-time prediction that allows professionals to personalize medical care, adjust and individualize therapy, and improve safety, and offers information that can help to improve clinical decision-making, enabling the medical community to effectively monitor patient health, track progress, and avoid adverse events.
- Sector
- Healthcare
- HQ
- Barcelona, Spain
- Founded
- 2019
- Employees
- 7
- Website
- predictheon.com/
- Ownership
- Privately Held (backing)
Predictheon doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Predictheon shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Predictheon in its N-PORT filings yet. We sweep new filings monthly.